Should We Perform Thoracic Imaging for Every Patient with a Renal Mass?
Journal Title: Üroonkoloji Bülteni - Year 2016, Vol 15, Issue 3
Abstract
Objective: Current guidelines for the management of renal mass recommend thoracic imaging for potential metastatic nodules. Small size of the renal mass can be associated with low metastatic potential, which might question the necessity of thoracic imaging in this patient population. This study sought to evaluate the association of thoracic imaging findings with the renal mass characteristics in patients with pathologically proven renal cell carcinoma (RCC). Materials and Methods: We performed a retrospective analysis of patients with RCC, who underwent radical/partial nephrectomy and had baseline thoracic imaging available for review. Patients with a suspicious pulmonary mass were evaluated by the Department of Thoracic Surgery. Presence of lung nodule(s) and metastasis was determined and compared with patient and renal mass characteristics. Results: A total of 215 patients were included in the study. Pulmonary nodules suspicious for malignancy were present in 26.8% of the cases and 42% of these patients underwent further examination for the presence of a pulmonary mass. Pathological examination of the pulmonary nodule revealed RCC metastasis in 80% of patients who underwent biopsy or excision of the pulmonary nodule. Of note, in the subgroup analysis according to the pathological stage of the renal mass, 19.3% of patients with pT1a disease had a suspicious pulmonary mass on thoracic imaging. Of these patients, 25% underwent further examination of the pulmonary nodule with a RCC metastasis in 66.6%. Conclusion: The presence of suspicious lung nodules in patients with RCC has metastatic potential regardless of the size of the renal mass. These findings underscore the importance of baseline thoracic imaging and vigilant further evaluation of patients in whom pulmonary nodules are identified.
Authors and Affiliations
Ahmet Şahan, Asgar Garayev, Murat Akgül, Tarık Emre Şener, Serdar Evman, Hasan Batırel, Emine Baş Bozkurtlar, Rengin Ahıskalı, Levent Türkeri, İlker Tinay
Keywords
Related Articles
- EP ID EP228288
- DOI 10.4274/uob.678
- Views 95
- Downloads 0
Active Surveillance in Prostate Cancer: Can We Expand the Indications?
Common usage of prostate-specific antigen screening and prostate biopsies increases diagnosis rate of “clinically insignificant prostate cancer”. Nowadays, active surveillance is an alternative approach for overtreatment...
Rebiopsy Results of the Patients in Which the First Biopsy Revealed High Grade Prostatic Intraepithelial Neoplasia
Objective: The incidence of the prostate adenocarsinome (PCA) in the repeat prostate biopsy after the high grade prostatic intraepithelial neoplasia (HGPIN) diagnosis has decreased with the increase of the quadrant numbe...
Bellini Duct Carcinoma: Case Report and Review of the Literature
Bellini duct carcinoma is highly aggressive tumor with poor prognosis. Metastases develop in most patients. Early diagnosis is very important and might increase the patient’s life span. Various treatment protocols includ...
The Effect of Framingham Score on the Oncological Outcomes in Localized (T1-T2 Stage) Renal Cell Carcinoma Patients
Objective: To evaluate the effect of cardiovascular disease risk on local recurrence, distant metastasis development and cancer-specific survival in patients with localized (stage 1 and 2) renal cell carcinoma (RCC). Mat...
A New Era in Metastatic Prostate Cancer: “The Combination of Chemotherapy and Hormonal Treatment as Initial Treatment”
In recent years, studies have been reported about the combination of androgen deprivation therapy (ADT) and different chemotherapy modalities as the initial therapy in newly-diagnosed patients with hormone-sensitive meta...